Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction
Patrycja A Naesgaard, Heidi Grundt, Arne F Nordøy, Harry Staines, Dennis W T Nilsen, Patrycja A Naesgaard, Heidi Grundt, Arne F Nordøy, Harry Staines, Dennis W T Nilsen
Abstract
Background: Fish is the natural dietary source of vitamin D. Reports on the influence of purified omega-3 fatty acids on its uptake are scarce.
Objectives: We investigated the impact of a purified high-dose omega-3 compound compared to corn oil on 25-hydroxyvitamin D [25(OH)D] levels following an acute myocardial infarction.
Methods: 228 patients were randomized 1:1 to receive a daily dose of either 4 g omega-3 (OMACOR®) or an equal dose of corn oil, administered double-blindly for 12 months. Total omega-3 and omega-6 measurements were available in 40 randomly picked patients.
Results: There was no significant intergroup difference in 25(OH)D changes at 12 months follow-up (p = 0.12), but there was a minor statistical significant intragroup increase in 25(OH)D in both intervention arms (p < 0.001 for n-3 polyunsaturated fatty acids and p = 0.013 for corn oil, respectively). A positive correlation was noted between 25(OH)D and omega-3 prior to inclusion; r = 0.418, p = 0.007, attenuated at 12 months by purified omega-3 intervention; r = 0.021, p = 0.93. No positive correlation was observed between omega-6 and 25(OH)D.
Conclusion: Long-term treatment with a high dose of purified omega-3 as compared to corn oil did not improve serum concentrations of vitamin D.
Clinical trial registration: ClinicalTrials.gov, Identifier: NCT01422317.
Keywords: 25-hydroxyvitamin D; acute myocardial infarction; omega-3; omega-6; vitamin D.
Figures
References
- DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr (2004) 80:1689S–96S.
- Grossmann RE, Tangpricha V. Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol Nutr Food Res (2010) 54:1055–61.10.1002/mnfr.200900578
- Naesgaard PA, León De La Fuente RA, Nilsen ST, Woie L, Aarsland T, Brede C, et al. Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PLoS One (2012) 7:e43228.10.1371/journal.pone.0043228
- Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci (2009) 338:40–4.10.1097/MAJ.0b013e3181aaee91
- Aarsetoey H, Grundt H, Nygaard O, Nilsen DW. The role of long-chained marine N-3 polyunsaturated fatty acids in cardiovascular disease. Cardiol Res Pract (2012) 2012:303456.10.1155/2012/303456
- Nilsen DWT, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L. Effects of a highdose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr (2001) 74:50–6.
- Grundt H, Nilsen DWT, Mansoor MA, Nordøy A. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. Eur J Clin Nutr (2003) 57:793–800.10.1038/sj.ejcn.1601730
- Holvik K, Madar AA, Meyer HE, Lofthus CM, Stene LC. A randomised comparison of increase in serum 25-hydroxyvitamin D concentration after 4 weeks of daily oral intake of 10 microg cholecalciferol from multivitamin tablets or fish oil capsules in healthy young adults. Br J Nutr (2007) 98:620–5.10.1017/S000711450773074X
- Grundt H, Nilsen DW, Mansoor MA, Hetland Ø, Nordøy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb (2003) 33:88–95.10.1159/000073852
- Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, Parkkila S, et al. The effects of storage time and sampling season on the stability of serum 25-hydroxyvitamin D and androstenedione. Nutr Cancer (2010) 62:51–7.10.1080/01635580903191460
- Nordøy A, Bønaa KH, Nilsen H, Berge RK, Hansen JB, Ingebretsen OC. Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. J Intern Med (1998) 243:163–70.10.1046/j.1365-2796.1998.00297.x
- Dawson-Hughes B, Harris SS, Lichtenstein AH, Dolnikowski G, Palermo NJ, Rasmussen H. Dietary fat increases vitamin D-3 absorption. J Acad Nutr Diet (2015) 115:225–30.10.1016/j.jand.2014.09.014
- Itariu BK, Zeyda M, Leitner L, Marculescu R, Stulnig TM. Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial. PLoS One (2013) 8:e54634.10.1371/journal.pone.0054634
- Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr (2003) 77:1478–83.
- Olsen KS, Aksnes L, Frøyland L, Lund E, Rylander C. Vitamin D status and PUFA ratios in a national representative cross-section of healthy, middle-aged Norwegian women – the Norwegian Women and Cancer Post-Genome Cohort. Scand J Public Health (2014) 42:814–20.10.1177/1403494814550519
- Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 2:757–61.10.1016/S0140-6736(89)90828-3
- Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med (2010) 363:2015–26.10.1056/NEJMoa1003603
- Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study cohort I. Circulation (2006) 113:195–202.10.1161/CIRCULATIONAHA.105.581355
- The ORIGIN Trial Investigators. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 367:1760–1.10.1056/NEJMc1210552
- Marchioli R. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet (1999) 354:447–55.10.1016/S0140-6736(99)07072-5
- Gissi-HF Investigators. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 372:1223–30.10.1016/S0140-6736(08)61239-8
- ASCEND. A Study of Cardiovascular Events in Diabetes 2011. Available from: . Accessed July 1, 2011
- Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 369:1090–8.10.1016/S0140-6736(07)60527-3
- Kwak SM, Myung SK, Lee YJ, Seo HG, Korean Meta-analysis Study Group . Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med (2012) 172:686–94.10.1001/archinternmed.2012.262
- Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 160:398–406.10.7326/M13-1788
Source: PubMed